Pamicell Stock Price at 19,300 KRW... Down 1.03% from Previous Day
As of 9:30 AM on the 7th, Pamicell is trading at 19,300 KRW, down 1.03% from the previous day. This represents a 10.23% decrease compared to September 7. Pamicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Over the past five days, individual investors have net purchased 158,642 shares, while foreigners and institutions have net sold 113,879 shares and 558 shares, respectively.
On October 5, Pamicell became a market issue with the headline 'Soars on news of President Trump's Remdesivir treatment.'
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
※Source: AI Investment Assistant AI Racciro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
